BioMerieux SA Share Price Xetra
Equities
EYW
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.9B 4.25B 332B | Sales 2025 * | 4.19B 4.56B 357B | Capitalization | 11.48B 12.5B 977B |
---|---|---|---|---|---|
Net income 2024 * | 468M 509M 39.84B | Net income 2025 * | 529M 576M 45.03B | EV / Sales 2024 * | 2.88 x |
Net cash position 2024 * | 264M 288M 22.49B | Net cash position 2025 * | 447M 486M 38.03B | EV / Sales 2025 * | 2.63 x |
P/E ratio 2024 * |
25.1
x | P/E ratio 2025 * |
22.2
x | Employees | - |
Yield 2024 * |
0.89% | Yield 2025 * |
1.03% | Free-Float | 36.23% |
Latest transcript on BioMerieux SA
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 31/10/16 |
Chairman | 50 | 15/04/04 | |
Director of Finance/CFO | 47 | 28/02/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 14/09/06 | |
Director/Board Member | 63 | 31/12/04 | |
Chairman | 50 | 15/04/04 |
1st Jan change | Capi. | |
---|---|---|
-0.60% | 8.22B | |
+6.61% | 5.72B | |
-10.21% | 4.11B | |
-59.99% | 2.68B | |
+10.62% | 2.68B | |
-5.60% | 2.37B | |
+19.23% | 2.06B | |
-9.18% | 1.8B | |
-2.30% | 1.6B |